ERBB2 and breast carcinoma: Thus, a possible reason for the lower level of TNBC and HER2 positive breast cancer in our study compared to the published studies is that the published studies include women diagnosed at younger ages before 50, while we focused on a population with the age of breast cancer diagnosis ≥50.